Follow the Science: How Big Pharma Misleads, Obscures, and Prevails

by Sharyl Attkisson

With the FDA’s new maneuver, in the rare cases where it will be given in the hospital, it will be too late. That will skew any reviews of its worth, making it look like it just isn’t effective.